Imatinib and binimetinib combination is a potential effective treatment for advanced gastrointestinal stromal tumours
1. Combination-treatment resulted in a best ORR of 69.0% and median PFS of 29.9 months 2. MEK inhibition toxicities included ...
1. Combination-treatment resulted in a best ORR of 69.0% and median PFS of 29.9 months 2. MEK inhibition toxicities included ...
1. The use of a type I KIT inhibitor, such as PLX9486, in combination with a type II inhibitor, such ...
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.